Nalls Sherbakoff Group, LLC Neogenomics Inc Transaction History
Nalls Sherbakoff Group, LLC
- $112 Billion
- Q4 2023
A detailed history of Nalls Sherbakoff Group, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 7 shares of NEO stock, worth $67. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7
Previous 14
50.0%
Holding current value
$67
Previous $173,000
34.1%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
307Shares Held
127MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$191 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$137 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$72 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$66.3 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$49.5 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.22B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...